Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 365

1.

A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence.

Ghoniem GM, Van Leeuwen JS, Elser DM, Freeman RM, Zhao YD, Yalcin I, Bump RC; Duloxetine/Pelvic Floor Muscle Training Clinical Trial Group.

J Urol. 2005 May;173(5):1647-53.

PMID:
15821528
2.

Economic evaluation of duloxetine for the treatment of women with stress urinary incontinence: a Markov model comparing pharmacotherapy with pelvic floor muscle training.

Brunenberg DE, Joore MA, Veraart CP, Berghmans BC, van der Vaart CH, Severens JL.

Clin Ther. 2006 Apr;28(4):604-18.

PMID:
16750472
3.
4.

Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women.

Ayeleke RO, Hay-Smith EJ, Omar MI.

Cochrane Database Syst Rev. 2015 Nov 3;(11):CD010551. doi: 10.1002/14651858.CD010551.pub3. Review.

PMID:
26526663
5.

Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women.

Ayeleke RO, Hay-Smith EJ, Omar MI.

Cochrane Database Syst Rev. 2013 Nov 20;(11):CD010551. doi: 10.1002/14651858.CD010551.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;(11):CD010551.

PMID:
24259154
6.
7.

Pharmacological treatment of women awaiting surgery for stress urinary incontinence.

Cardozo L, Drutz HP, Baygani SK, Bump RC.

Obstet Gynecol. 2004 Sep;104(3):511-9.

PMID:
15339761
8.

Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence.

van Kerrebroeck P, Abrams P, Lange R, Slack M, Wyndaele JJ, Yalcin I, Bump RC; Duloxetine Urinary Incontinence Study Group.

BJOG. 2004 Mar;111(3):249-57.

9.

Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.

Millard RJ, Moore K, Rencken R, Yalcin I, Bump RC; Duloxetine UI Study Group.

BJU Int. 2004 Feb;93(3):311-8.

PMID:
14764128
10.

Efficacy and safety of duloxetine in elderly women with stress urinary incontinence or stress-predominant mixed urinary incontinence.

Schagen van Leeuwen JH, Lange RR, Jonasson AF, Chen WJ, Viktrup L.

Maturitas. 2008 Jun 20;60(2):138-47. doi: 10.1016/j.maturitas.2008.04.012. Epub 2008 Jun 10.

PMID:
18547757
11.

EMG-biofeedback assisted pelvic floor muscle training is an effective therapy of stress urinary or mixed incontinence: a 7-year experience with 390 patients.

Dannecker C, Wolf V, Raab R, Hepp H, Anthuber C.

Arch Gynecol Obstet. 2005 Dec;273(2):93-7. Epub 2005 Jul 6.

PMID:
16001201
12.

Duloxetine versus placebo in the treatment of stress urinary incontinence.

Norton PA, Zinner NR, Yalcin I, Bump RC; Duloxetine Urinary Incontinence Study Group.

Am J Obstet Gynecol. 2002 Jul;187(1):40-8.

PMID:
12114886
13.

A double-blind randomized controlled trial of electromagnetic stimulation of the pelvic floor vs sham therapy in the treatment of women with stress urinary incontinence.

Gilling PJ, Wilson LC, Westenberg AM, McAllister WJ, Kennett KM, Frampton CM, Bell DF, Wrigley PM, Fraundorfer MR.

BJU Int. 2009 May;103(10):1386-90. doi: 10.1111/j.1464-410X.2008.08329.x. Epub 2009 Jan 14.

14.

Duloxetine: in stress urinary incontinence.

McCormack PL, Keating GM.

Drugs. 2004;64(22):2567-73; discussion 2574-5. Review.

PMID:
15516154
15.

Pelvic floor muscle training is effective in women with urinary incontinence after stroke: a randomised, controlled and blinded study.

Tibaek S, Gard G, Jensen R.

Neurourol Urodyn. 2005;24(4):348-57. Erratum in: Neurourol Urodyn. 2008;27(1):100.

PMID:
15791633
16.

Short- and long-term efficacy and safety of duloxetine in women with predominant stress urinary incontinence.

Cardozo L, Lange R, Voss S, Beardsworth A, Manning M, Viktrup L, Zhao YD.

Curr Med Res Opin. 2010 Feb;26(2):253-61. doi: 10.1185/03007990903438295.

PMID:
19929591
17.

Evaluation of the effect of pelvic floor muscle training (PFMT or Kegel exercise) and assisted pelvic floor muscle training (APFMT) by a resistance device (Kegelmaster device) on the urinary incontinence in women: a randomized trial.

Kashanian M, Ali SS, Nazemi M, Bahasadri S.

Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):218-23. doi: 10.1016/j.ejogrb.2011.06.037. Epub 2011 Jul 7.

PMID:
21741151
18.

The long-term effectiveness of antenatal pelvic floor muscle training: eight-year follow up of a randomised controlled trial.

Agur WI, Steggles P, Waterfield M, Freeman RM.

BJOG. 2008 Jul;115(8):985-90. doi: 10.1111/j.1471-0528.2008.01742.x.

19.

Duloxetine in the treatment of women with stress urinary incontinence: results from DESIRE (Duloxetine Efficacy and Safety for Incontinence in Racial and Ethnic populations).

Weinstein DL, Cohen JS, Liu C, Meadows ES, Plouffe L Jr, Muram D; DESIRE Study Group.

Curr Med Res Opin. 2006 Nov;22(11):2121-9.

PMID:
17076972
20.

Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.

Mariappan P, Alhasso A, Ballantyne Z, Grant A, N'Dow J.

Eur Urol. 2007 Jan;51(1):67-74. Epub 2006 Sep 15. Review.

PMID:
17014950

Supplemental Content

Support Center